138 related articles for article (PubMed ID: 9396085)
1. Involvement of cholinergic and opioid receptor mechanisms in nicotine-induced antinociception.
Zarrindast MR; Pazouki M; Nassiri-Rad S
Pharmacol Toxicol; 1997 Nov; 81(5):209-13. PubMed ID: 9396085
[TBL] [Abstract][Full Text] [Related]
2. Nicotine potentiates morphine antinociception: a possible cholinergic mechanism.
Zarrindast MR; Nami AB; Farzin D
Eur Neuropsychopharmacol; 1996 May; 6(2):127-33. PubMed ID: 8791038
[TBL] [Abstract][Full Text] [Related]
3. Repeated administration of nicotine attenuates the development of morphine tolerance and dependence in mice.
Haghparast A; Khani A; Naderi N; Alizadeh AM; Motamedi F
Pharmacol Biochem Behav; 2008 Feb; 88(4):385-92. PubMed ID: 17915302
[TBL] [Abstract][Full Text] [Related]
4. On the mechanism of cross-tolerance between morphine- and nicotine-induced antinociception: involvement of calcium channels.
Biala G; Weglinska B
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jan; 30(1):15-21. PubMed ID: 16202496
[TBL] [Abstract][Full Text] [Related]
5. Naloxone precipitates nicotine abstinence syndrome and attenuates nicotine-induced antinociception in mice.
Biała G; Budzyńska B; Kruk M
Pharmacol Rep; 2005; 57(6):755-60. PubMed ID: 16382193
[TBL] [Abstract][Full Text] [Related]
6. Morphine-induced place preference: involvement of cholinergic receptors of the ventral tegmental area.
Rezayof A; Nazari-Serenjeh F; Zarrindast MR; Sepehri H; Delphi L
Eur J Pharmacol; 2007 May; 562(1-2):92-102. PubMed ID: 17336285
[TBL] [Abstract][Full Text] [Related]
7. Nicotinic receptor involvement in antinociception induced by exposure to cigarette smoke.
Simons CT; Cuellar JM; Moore JA; Pinkerton KE; Uyeminami D; Carstens MI; Carstens E
Neurosci Lett; 2005 Dec; 389(2):71-6. PubMed ID: 16095820
[TBL] [Abstract][Full Text] [Related]
8. Involvement of spinal Met-enkephalin in nicotine-induced antinociception in mice.
Kiguchi N; Maeda T; Tsuruga M; Yamamoto A; Yamamoto C; Ozaki M; Kishioka S
Brain Res; 2008 Jan; 1189():70-7. PubMed ID: 18048009
[TBL] [Abstract][Full Text] [Related]
9. The effects of morphine, nicotine and epibatidine on lymphocyte activity and hypothalamic-pituitary-adrenal axis responses.
Mellon RD; Bayer BM
J Pharmacol Exp Ther; 1999 Feb; 288(2):635-42. PubMed ID: 9918569
[TBL] [Abstract][Full Text] [Related]
10. Varenicline and mecamylamine attenuate locomotor sensitization and cross-sensitization induced by nicotine and morphine in mice.
Biala G; Staniak N
Pharmacol Biochem Behav; 2010 Aug; 96(2):141-7. PubMed ID: 20451547
[TBL] [Abstract][Full Text] [Related]
11. Influence of nicotinic receptor modulators on CB2 cannabinoid receptor agonist (JWH133)-induced antinociception in mice.
Jafari MR; Golmohammadi S; Ghiasvand F; Zarrindast MR; Djahanguiri B
Behav Pharmacol; 2007 Nov; 18(7):691-7. PubMed ID: 17912054
[TBL] [Abstract][Full Text] [Related]
12. Potentiation of imipramine-induced antinociception by nicotine in the formalin test.
Zarrindast MR; Baghdadi B; Sahebgharani M
Eur Neuropsychopharmacol; 2004 Jan; 14(1):71-6. PubMed ID: 14659990
[TBL] [Abstract][Full Text] [Related]
13. Cross-tolerance between morphine- and nicotine-induced conditioned place preference in mice.
Zarrindast MR; Faraji N; Rostami P; Sahraei H; Ghoshouni H
Pharmacol Biochem Behav; 2003 Jan; 74(2):363-9. PubMed ID: 12479956
[TBL] [Abstract][Full Text] [Related]
14. The role of nicotinic acetylcholine and opioid systems of the ventral orbital cortex in modulation of formalin-induced orofacial pain in rats.
Yousofizadeh S; Tamaddonfard E; Farshid AA
Eur J Pharmacol; 2015 Jul; 758():147-52. PubMed ID: 25864612
[TBL] [Abstract][Full Text] [Related]
15. Antinociceptive effect of diisopropylphosphofluoridate: development of tolerance and lack of cross-tolerance to morphine.
Costa LG; Murphy SD
Neurobehav Toxicol Teratol; 1985; 7(3):251-6. PubMed ID: 2993935
[TBL] [Abstract][Full Text] [Related]
16. The effects of oxotremorine, epibatidine, atropine, mecamylamine and naloxone in the tail-flick, hot-plate, and formalin tests in the naked mole-rat (Heterocephalus glaber).
Dulu TD; Kanui TI; Towett PK; Maloiy GM; Abelson KS
In Vivo; 2014; 28(1):39-48. PubMed ID: 24425834
[TBL] [Abstract][Full Text] [Related]
17. Antinociceptive and pharmacological effects of metanicotine, a selective nicotinic agonist.
Damaj MI; Glassco W; Aceto MD; Martin BR
J Pharmacol Exp Ther; 1999 Oct; 291(1):390-8. PubMed ID: 10490929
[TBL] [Abstract][Full Text] [Related]
18. Nicotine potentiation of morphine-induced catalepsy in mice.
Zarrindast MR; Samadi P; Haeri-Rohani A; Moazami N; Shafizadeh M
Pharmacol Biochem Behav; 2002 May; 72(1-2):197-202. PubMed ID: 11900788
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological relationship between nicotinic and opioid systems in analgesia and corticosterone elevation.
Yamamoto A; Kiguchi N; Kobayashi Y; Maeda T; Ueno K; Yamamoto C; Kishioka S
Life Sci; 2011 Dec; 89(25-26):956-61. PubMed ID: 22036617
[TBL] [Abstract][Full Text] [Related]
20. Morphine tolerance does not develop in mice treated with endothelin-A receptor antagonists.
Bhalla S; Matwyshyn G; Gulati A
Brain Res; 2005 Dec; 1064(1-2):126-35. PubMed ID: 16289404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
